About HealthReady
The SMHS HealthReady Pipeline provides a ‘foot in the door’ for start-ups and innovators to test and validate their innovations in a public healthcare environment. It provides support at different points in development right up until the idea is market ready.
The pipeline provides innovators and start-ups with a simple, easy and streamlined way for engaging with key healthcare decision makers and clinical experts. No more searching for the best way to test ideas, because it’s here in the SMHS HealthReady Pipeline.
The pipeline leverages innovation resources at SMHS, including access to clinical staff and consumers. It’s all about collaboration and helping bridge the gap between innovators and the healthcare service, who is often the final user of innovative ideas.
Through the pipeline, SMHS becomes part of developing the innovation rather than just an end user. The pipeline closes the gap between the innovator and healthcare service by:
- helping innovators understand patient needs and the healthcare system
- giving innovators access to clinical and non-clinical experts during innovation development
- engaging patients and/or consumers to give quality feedback
- validating the innovation within actual clinical workflows
- acknowledging potential solutions that already exist in the market
- raising opportunities to address specific areas of need.
Everyone benefits from the SMHS HealthReady Pipeline.
For innovators and start-ups, it helps to:
- streamline product development and validation
- deliver an innovation sustainable within a healthcare setting
- accelerate dissemination of a health ready product or idea.
For patients and the Western Australian (WA) community, early participation means:
- trust in innovations developed for their care
- quicker access to innovations within a healthcare setting
- greater support of health care innovation in WA.
SMHS will have:
- early access to new products
- enablement of new models of care
- reputation enhancement as a supportive health organisation
- growth as an innovation incubator.
For the WA health system, it will:
- demonstrate support for WA’s innovator and start-up industry
- provide consistent model of healthcare innovation in HSPs and growing profile as an innovation centre of excellence
- increase agility in translating ideas / research into implemented products.
Continuous improvement – the risk of doing nothing is greater than the risk of doing something.
Outcomes focussed – dream big, but bring it back to the heart (purpose). Must be in line with WA Health and SMHS strategies.
Co-design and collaboration – across industry and with consumers to create value.
Fail fast – be guided based on need and learn from failings.
Confidentiality – commercially sensitive information will be kept confidential.
Sustainable – the program is environmentally sustainable, self-sustaining, and encourages wise utilisation of resources.
No wrong door approach – products will be tested in the right environment based on need.
Intellectual property – intellectual property (IP) will be managed in accordance with individual need and in line with WA Government IP policies.